Icosavax Raises $100m To Take RSV, COVID-19 Vaccines Into The Clinic

Platform Enables Vaccines Based On Non-Naturally Occurring VLPs

 
• By Mandy Jackson
  
Vaccine vial dose
Icosavax's first vaccines aim to prevent COVID-19 and pneumonia • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business